Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155]

Status:

Topic prioritisation

Technology type:

Medicine

Decision:

Not selected

Reason for decision:

Not eligible for Health Technology Evaluation guidance

ID number:

12155

Project Team

Project lead

Danielle Lees

Email enquiries

If you have any queries please email topic.selection@nice.org.uk

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about topic prioritisation